SCA Pharmaceuticals is recalling 183 bags of FentaNYL (fentanyl) and Bupivacaine HCl (bupivacaine hydrochloride) in Sodium Chloride injection bags used for epidural anesthesia. This recall was initiated because units that were previously rejected for quality control issues were accidentally shipped to hospitals and clinics. No injuries have been reported to date, but the use of these rejected units could lead to patient harm due to potential sterility issues or incorrect drug concentrations.
The shipment of rejected units means these medications did not meet strict manufacturing and quality standards. Using these units could expose patients to contaminated medication or improper dosages during epidural administration.
Recall #: D-0945-2023. Units affected: 183 bags. Recalled due to shipment of rejected units.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.